4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-006274
Options or other derivatives
- President and CEO acquired 1,165,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-15 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +1,165,100 | 1,165,100 | D |
Loading xslF345X03/ownership.xml…